The Contribution of Endothelial Activation and Injury to End-Organ Toxicity following Allogeneic Hematopoietic Stem Cell Transplantation
Open Access
- 1 January 2008
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 14 (1), 23-32
- https://doi.org/10.1016/j.bbmt.2007.10.008
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Role for Tumor Necrosis Factor-α-Mediated Endothelial Apoptosis in the Development of Experimental Idiopathic Pneumonia SyndromeTransplantation, 2004
- Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantationBlood, 2003
- Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.Transplantation and Cellular Therapy, 2002
- CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implicationsBlood, 2002
- Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantationBone Marrow Transplantation, 2001
- Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host diseaseBone Marrow Transplantation, 1997
- IDIOPATHIC PNEUMONIA SYNDROMETransplantation, 1997
- INFLUENCE OF BACTERIAL ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL CELLS IN VITRO AND IN VIVOTransplantation, 1996
- Idiopathic Pneumonia Syndrome after Bone Marrow TransplantationAmerican Review of Respiratory Disease, 1993
- Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantationBlood, 1989